145 related articles for article (PubMed ID: 35750378)
1. Retrospective analysis of comorbidities in stroke patients with a history of obstructive sleep apnea treated with thrombolytic therapy.
Knisely K; Sanders CB; Edrissi C; Rathfoot C; Poupore N; Bailey-Taylor MJ; Stewart B; Nathaniel T
J Vasc Nurs; 2022 Jun; 40(2):74-85. PubMed ID: 35750378
[TBL] [Abstract][Full Text] [Related]
2. Acute Ischemic Stroke and Heart Failure: Stroke Risk Factors Associated with Exclusion from Thrombolytic Therapy.
Sanders CB; Knisely K; Rathfoot C; Edrissi C; Nathaniel T
Clin Appl Thromb Hemost; 2022; 28():10760296221116347. PubMed ID: 36278505
[No Abstract] [Full Text] [Related]
3. Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy.
Inohara T; Liang L; Kosinski AS; Smith EE; Schwamm LH; Hernandez AF; Bhatt DL; Fonarow GC; Peterson ED; Xian Y
J Am Heart Assoc; 2019 Aug; 8(15):e012450. PubMed ID: 31327296
[TBL] [Abstract][Full Text] [Related]
4. Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia.
Blum B; Wormack L; Holtel M; Penwell A; Lari S; Walker B; Nathaniel TI
BMC Womens Health; 2019 Jan; 19(1):11. PubMed ID: 30651099
[TBL] [Abstract][Full Text] [Related]
5. Gender disparity in a cohort of stroke patients with incidence of obstructive sleep apnea.
Edrissi C; Rathfoot C; Knisely K; Sanders CB; Poupore N; Nathaniel T
J Vasc Nurs; 2022 Mar; 40(1):17-27. PubMed ID: 35287829
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors Associated With Exclusion of Obese Patients Ischemic Stroke With a History of Smoking From Thrombolysis Therapy.
Brewer PC; Ojo DT; Broughton PX; Imeh-Nathaniel A; Imeh-Nathaniel S; Nathaniel TI
Clin Appl Thromb Hemost; 2024; 30():10760296241246264. PubMed ID: 38600881
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients.
Poupore N; Strat D; Mackey T; Brown K; Snell A; Nathaniel TI
Lipids Health Dis; 2020 May; 19(1):84. PubMed ID: 32375780
[TBL] [Abstract][Full Text] [Related]
8. Thrombolytic therapy in ischemic stroke patients with pre-stroke depression in the telestroke vs non-telestroke.
Moraney R; Poupore N; Shugart R; Tate M; Snell A; Brown K; Nathaniel TI
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):104890. PubMed ID: 32807408
[TBL] [Abstract][Full Text] [Related]
9. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
10. Ischemic stroke with a preceding Trans ischemic attack (TIA) less than 24 hours and thrombolytic therapy.
Poupore N; Strat D; Mackey T; Snell A; Nathaniel T
BMC Neurol; 2020 May; 20(1):197. PubMed ID: 32429850
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and ambulatory outcome in ischemic stroke patients with pre-stroke depression.
Okon M; Blum B; Nathaniel TI
J Vasc Nurs; 2021 Dec; 39(4):91-99. PubMed ID: 34865727
[TBL] [Abstract][Full Text] [Related]
12. Absolute blood eosinophil count could be a potential biomarker for predicting haemorrhagic transformation after intravenous thrombolysis for acute ischaemic stroke.
Jucevičiūtė N; Mikužis P; Balnytė R
BMC Neurol; 2019 Jun; 19(1):127. PubMed ID: 31195995
[TBL] [Abstract][Full Text] [Related]
13. Predictors of thrombolysis in the telestroke and non telestroke settings for hypertensive acute ischemic stroke patients.
Brecthel L; Gainey J; Penwell A; Nathaniel TI
BMC Neurol; 2018 Dec; 18(1):215. PubMed ID: 30577762
[TBL] [Abstract][Full Text] [Related]
14. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years.
Adeoye O; Hornung R; Khatri P; Kleindorfer D
Stroke; 2011 Jul; 42(7):1952-5. PubMed ID: 21636813
[TBL] [Abstract][Full Text] [Related]
15. Recombinant tissue plasminogen activator (rTPA) management for first onset acute ischemic stroke with covid -19 and non-covid -19 patients.
Khedr EM; Abdelwarith A; Moussa G; Saber M
J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107031. PubMed ID: 36701854
[TBL] [Abstract][Full Text] [Related]
16. Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke.
Nathaniel TI; Gainey J; Blum B; Montgomery C; Ervin L; Madeline L
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2524-2533. PubMed ID: 29859864
[TBL] [Abstract][Full Text] [Related]
17. [Effect of obstructive sleep apnea on sleep architecture of acute ischemic stroke patients].
Xu YN; Li J; Huang JY; Zhu C; Mao CJ; Shen Y; Liu CF
Zhonghua Yi Xue Za Zhi; 2017 Mar; 97(12):920-924. PubMed ID: 28355753
[No Abstract] [Full Text] [Related]
18. Gender and thrombolysis therapy in acute ischemic stroke patients with incidence of obesity.
Blum B; Penwell A; Wormack L; Walker B; Lari S; Nathaniel TI
Neurol Sci; 2019 Sep; 40(9):1829-1839. PubMed ID: 31049791
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-lymphocyte ratio in predicting neurologic outcome of patients with acute ischemic stroke treated with intravenous thrombolytics.
Chen CT; Li LH; Su PY; Chang YC; Lee IH; Yen DH; How CK
J Chin Med Assoc; 2022 Jan; 85(1):102-108. PubMed ID: 34380992
[TBL] [Abstract][Full Text] [Related]
20. Peripheral Monocyte Count Predicts Outcomes in Patients with Acute Ischemic Stroke Treated with rtPA Thrombolysis.
Dong X; Nao J; Gao Y
Neurotox Res; 2020 Feb; 37(2):469-477. PubMed ID: 31478125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
